GeneGoCell Insights
Stay informed, stay productive with all the latest from GeneGoCell.
AAV Integration and Cancer Risk: From Theoretical Risk to Molecular Evidence
By Dr. Aaron Zhang-Chen, CQA, PhD, CTO at GeneGoCell on November 9, 2026
FDA’s 2026 Zolgensma safety alert highlights GLI1-related insertional oncogenesis and the importance of sensitive AAV integration-site testing in gene therapy.
G-Amp-HT℠ High-Throughput NGS Genotyping
By Dr. Aaron Zhang-Chen, CQA, PhD on September 14, 2026
Explore G-Amp-HT℠, GeneGoCell’s high-throughput NGS genotyping workflow for 1% allele-frequency resolution, rapid clone screening, and multi-sample studies.